Reeves Mark E, Baldwin Melissa L, Aragon Robert, Baldwin Scott, Chen Shin-Tai, Li Xinmin, Mohan Subburaman, Amaar Yousef G
Surgical Oncology Laboratory, Loma Linda VA Medical Center, CA 92357, USA.
BMC Res Notes. 2012 May 16;5:239. doi: 10.1186/1756-0500-5-239.
RASSF1A and RASSF1C are two major isoforms encoded by the Ras association domain family 1 (RASSF1) gene through alternative promoter selection and mRNA splicing. RASSF1A is a well established tumor suppressor gene. Unlike RASSF1A, RASSF1C appears to have growth promoting actions in lung cancer. In this article, we report on the identification of novel RASSF1C target genes in non small cell lung cancer (NSCLC).
Over-expression and siRNA techniques were used to alter RASSF1C expression in human lung cancer cells, and Affymetrix-microarray study was conducted using NCI-H1299 cells over-expressing RASSF1C to identify RASSF1C target genes.
The microarray study intriguingly shows that RASSF1C modulates the expression of a number of genes that are involved in cancer development, cell growth and proliferation, cell death, and cell cycle. We have validated the expression of some target genes using qRT-PCR. We demonstrate that RASSF1C over-expression increases, and silencing of RASSF1C decreases, the expression of PIWIL1 gene in NSCLC cells using qRT-PCR, immunostaining, and Western blot analysis. We also show that RASSF1C over-expression induces phosphorylation of ERK1/2 in lung cancer cells, and inhibition of the MEK-ERK1/2 pathway suppresses the expression of PIWIL1 gene expression, suggesting that RASSF1C may exert its activities on some target genes such as PIWIL1 through the activation of the MEK-ERK1/2 pathway. Also, PIWIL1 expression is elevated in lung cancer cell lines compared to normal lung epithelial cells.
Taken together, our findings provide significant data to propose a model for investigating the role of RASSF1C/PIWIL1 proteins in initiation and progression of lung cancer.
RASSF1A和RASSF1C是由Ras关联结构域家族1(RASSF1)基因通过选择性启动子选择和mRNA剪接编码的两种主要亚型。RASSF1A是一个公认的肿瘤抑制基因。与RASSF1A不同,RASSF1C在肺癌中似乎具有促进生长的作用。在本文中,我们报告了在非小细胞肺癌(NSCLC)中新型RASSF1C靶基因的鉴定。
使用过表达和siRNA技术改变人肺癌细胞中RASSF1C的表达,并使用过表达RASSF1C的NCI-H1299细胞进行Affymetrix微阵列研究以鉴定RASSF1C靶基因。
微阵列研究有趣地表明,RASSF1C调节许多参与癌症发展、细胞生长和增殖、细胞死亡及细胞周期的基因的表达。我们使用qRT-PCR验证了一些靶基因的表达。我们通过qRT-PCR、免疫染色和蛋白质印迹分析证明,RASSF1C过表达增加,而RASSF1C沉默降低NSCLC细胞中PIWIL1基因的表达。我们还表明,RASSF1C过表达诱导肺癌细胞中ERK1/2的磷酸化,并且抑制MEK-ERK1/2途径抑制PIWIL1基因表达,这表明RASSF1C可能通过激活MEK-ERK1/2途径对一些靶基因如PIWIL1发挥其作用。此外,与正常肺上皮细胞相比,PIWIL1在肺癌细胞系中的表达升高。
综上所述,我们的研究结果提供了重要数据,为研究RASSF1C/PIWIL1蛋白在肺癌发生和发展中的作用提出了一个模型。